Remove Blogging Remove Invest Remove San Diego Remove Training
article thumbnail

In Wake Of Infamous Biotech Party, 20 Women Join New Exec Training

Xconomy

In other circumstances the five-day workshop, scheduled this fall at George Washington University in the nation’s capital, might go unnoticed among the sea of executive training programs offered every day. The bank, LifeSci Advisors, is looking to pay penance by helping fund the training program. Morgan conference in January.

article thumbnail

As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown

Xconomy

Castle Biosciences is joining the public markets through a $64 million IPO that will support cancer tests that help doctors make treatment decisions. On Wednesday evening, Castle priced its offering of 4 million shares at $16 apiece, which was the high end of its targeted price range. million shares in the range of $14 to $16 each.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

At “The Vine,” Developer Builds a Vertical Campus for Tech Startups

Xconomy

In downtown San Diego, a private real estate company best known for its master-planned communities in suburban Southern California has posed some existential questions for regional tech hubs looking to build their own startup ecosystems. 101 West Broadway tower in downtown San Diego. John “J.T.”

Develop 40
article thumbnail

Ostendo Raising Funds to Advance Virtual Reality Display Technology

Xconomy

The financing includes both new investment funding and a conversion of debt to equity, according to a notation in the filing. Adding to the confusion, the most-recent MoneyTree Report on San Diego venture capital activity shows that Ostendo raised almost $10 million in VC funding during the second quarter.

article thumbnail

Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More

Xconomy

President Trump’s opioid commission released its final report this week, calling for expansion of drug courts, better physician training, and penalties for insurers that don’t cover treatment. The rising death toll from opioids has prompted policymakers to try various ways to take on the problem.

News 49
article thumbnail

After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes?

Xconomy

Officials at Vertex Pharmaceuticals (NASDAQ: VRTX ), who were planning a move from Cambridge, MA, into a new $800 million headquarters with views of Boston Harbor, should have seen something much different in those Pharmasset data: An oncoming freight train. Has Vertex has learned from its past missteps?

Startup 40
article thumbnail

Tech Giants’ Partnership To Explore Ethics, Societal Impacts of AI

Xconomy

Each company is investing untold billions of dollars in developing AI technologies, betting on a future defined by computer systems that can perceive, reason, advise, and decide. The Partnership on AI , formally unveiled Wednesday, includes Amazon, Microsoft, Facebook, IBM, Google and its 2014 acquisition DeepMind.